Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Betterlife Pharma Inc (BETR.CN)

Betterlife Pharma Inc (BETR.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 7,595
  • Shares Outstanding, K 151,897
  • Annual Sales, $ 0 K
  • Annual Income, $ -3,520 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.69
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.01
  • Most Recent Earnings $0.00 on 09/29/25
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING:

    SIC-2834 Pharmaceutical Preparations

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0400 +25.00%
on 01/07/26
0.0500 unch
on 01/21/26
unch (unch)
since 12/19/25
3-Month
0.0400 +25.00%
on 01/07/26
0.0700 -28.57%
on 11/13/25
-0.0100 (-16.67%)
since 10/21/25
52-Week
0.0400 +25.00%
on 01/07/26
0.1750 -71.43%
on 01/23/25
-0.0800 (-61.54%)
since 01/21/25

Most Recent Stories

More News
BetterLife Pharma to Participate in YAFO Capital Access Asia Partnering Forum During JPM Week in San Francisco

Vancouver, British Columbia--(Newsfile Corp. - January 6, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company"), an emerging biopharmaceutical company...

BETRF : 0.0361 (-6.96%)
BETR.CN : 0.0500 (unch)
BetterLife Pharma Announces Engagement with Shanghai-Based YAFO Capital

Vancouver, British Columbia--(Newsfile Corp. - December 11, 2025) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company"), an emerging biotech company focused...

BETRF : 0.0361 (-6.96%)
BETR.CN : 0.0500 (unch)
BetterLife Pharma Provides Scientific Update on Neuroplastogenic Activity of BETR-001

BETR.CN : 0.0500 (unch)
BETRF : 0.0361 (-6.96%)
BetterLife Provides Comments on CEO’s Share Position Ownership and Recent BCSC Press Release

BETR.CN : 0.0500 (unch)
BETRF : 0.0361 (-6.96%)
BetterLife Pharma Provides Scientific Update of Mechanism of Action of BETR-001 in Treatment of Psychiatric Disorders

BETR.CN : 0.0500 (unch)
BETRF : 0.0361 (-6.96%)
BetterLife Announces Debt Settlements

BETR.CN : 0.0500 (unch)
BETRF : 0.0361 (-6.96%)
BetterLife Pharma Appoints Corporate Advisor

BETR.CN : 0.0500 (unch)
BETRF : 0.0361 (-6.96%)
BetterLife Pharma Appoints New Director

BETR.CN : 0.0500 (unch)
BETRF : 0.0361 (-6.96%)
USPTO Grants BetterLife’s BETR-001 Composition of Matter Patent

BETR.CN : 0.0500 (unch)
BETRF : 0.0361 (-6.96%)
BetterLife Announces Favorable Outcome in New York Legal Claims

BETR.CN : 0.0500 (unch)
BETRF : 0.0361 (-6.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and the European Union. It is involved in refining and developing drug candidates from a set of complementary...

See More

Key Turning Points

3rd Resistance Point 0.0500
2nd Resistance Point 0.0500
1st Resistance Point 0.0500
Last Price 0.0500
1st Support Level 0.0500
2nd Support Level 0.0500
3rd Support Level 0.0500

See More

52-Week High 0.1750
Fibonacci 61.8% 0.1234
Fibonacci 50% 0.1075
Fibonacci 38.2% 0.0916
Last Price 0.0500
52-Week Low 0.0400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar